EMA adopts guideline on requirements for clinical-stage ATMPs

Regulatory NewsRegulatory NewsAdvanced therapies/cell and gene therapyClinical TrialsEuropeGuidanceHuman cells, tissues, and cellular and tissue-based products (HCT/Ps)ICHManufacturingPediatric productsPreclinical studyProduct LifecycleRegulatory Intelligence/PolicyRisk management